Broadrick Amends BioRestorative Therapies Filing

TL;DR

Broadrick filed an update on BioRestorative Therapies (BRTX) - check for ownership changes.

AI Summary

Dale Broadrick filed an amendment (Amendment No. 9) to Schedule 13D on March 6, 2024, regarding BioRestorative Therapies, Inc. The filing indicates a change in the date of the event requiring this statement to February 8, 2024. Broadrick is listed as the person authorized to receive notices and communications, with a Nashville, TN address.

Why It Matters

This filing updates ownership information for BioRestorative Therapies, Inc., which could signal changes in control or investment strategy by Dale Broadrick.

Risk Assessment

Risk Level: medium — Schedule 13D filings often indicate significant stake changes, which can lead to volatility and require careful monitoring.

Key Players & Entities

• Dale Broadrick (person) — Filing person and authorized contact
• BioRestorative Therapies, Inc. (company) — Subject company
• February 8, 2024 (date) — Date of event requiring filing
• March 6, 2024 (date) — Filing date

FAQ

Key Financial Figures

• $120 — orting Person with an exercise price of $120 per Share and an expiration date of Feb
• $1.38 — e per Share February 7, 2024 36,374 $1.38 February 8, 2024 83,626 $1.34 Febru
• $1.34 — 6,374 $1.38 February 8, 2024 83,626 $1.34 February 8, 2024 73,959 $1.25 Febru
• $1.25 — 3,626 $1.34 February 8, 2024 73,959 $1.25 February 9, 2024 86,041 $1.32 Item
• $1.32 — 3,959 $1.25 February 9, 2024 86,041 $1.32 Item 6. Contracts, Arrangements, Under

Filing Documents

• db13da9.htm (SC 13D/A) — 59KB
• 0001021771-24-000065.txt ( ) — 60KB

Security and Issuer

Item 1. Security and Issuer. This statement relates to the shares of Common Stock, par value $.0001 per share ("Shares" or the "Common Stock"), of BioRestorative Therapies, Inc., a Nevada corporation (the "Company"). The address of the principal executive offices of the Company is 40 Marcus Drive, Suite One, Melville, New York 11747.

Identity and Background

Item 2. Identity and Background. a. Name Dale Broadrick b. Residence or Business Address 3003 Brick Church Pike Nashville, Tennessee 37207 c. Occupation The Reporting Person is a private investor. d. Convictions During the last five years, the Reporting Person, to the best of is knowledge, has not been convicted in a criminal proceeding (excluding traffic violations and similar misdemeanors). e. Civil Judgments During the last five years, the Reporting Person, to the best of his knowledge, has not been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is f. Citizenship The Reporting Person is a citizen of the United States of America.

Source or Amount of Funds or Other Consideration

Item 3. Source or Amount of Funds or Other Consideration. See Item 4.

Purpose of Transaction

Item 4. Purpose of Transaction. Between February 7, 2024 and February 9, 2024, the Reporting Person purchased, directly or indirectly, an aggregate of 280,000 Shares in the open market as set forth in Item 5. The Shares were acquired, and are being held, for investment purposes. The Reporting Person believes that the Common Stock of the Company is significantly undervalued and does not reflect the value of its business opportunity and its intellectual property. The Reporting Person may purchase additional shares of Common Stock from time to time depending upon price, market conditions, availability of funds, evaluation of other investment opportunities, and other factors. The Reporting Person has no present intention to sell any shares of Common Stock, although the Reporting Person could determine from time to time, based upon the same factors listed above for purchases, to sell some or all of the shares of Common Stock held by the Reporting Person. The Reporting Person does not have any plans or proposals that would result in any of the actions or transactions described in clauses (a) through (j) of Item 4 of Schedule 13D, except as set forth above. a. An Acquisition or Disposition b. A Corporate Transaction: c. A Sale or Transfer of Assets: d. A Change in Board of Directors: e. A Change in Capitalization: f. Other Material Change: g. Changes to Charter h. Causing Delisting: i. Termination of Registration: j. A Similar Action:

Interest in Securities of the Issuer

Item 5. Interest in Securities of the Issuer. a. As of February 9, 2024, the Reporting Person beneficially owned 926,376 shares of Common Stock of the Company, including 1,359 shares of Common Stock of the Company issuable upon the exercise of currently exercisable warrants. As of such date, the Reporting Person beneficially owned 14.1% of the outstanding Common Stock of the Company, based on there being 6,556,917 shares of Common Stock of the Company outstanding as of February 9, 2024 (based upon the number of shares of Common Stock outstanding as of November 10, 2023, as set forth in the Company's Quarterly Report on Form 10-Q for the period ended September 30, 2023, filed with the SEC on November 13, 2023, and the number of shares of Common Stock issued pursuant to the transaction discussed in the Company's Current Report on Form 8-K for an event dated February 6, 2024, filed with the SEC on February 8, 2024), and presently exercisable warrants issued to the Reporting Person for the purchase of an aggregate of 1,359 shares of Common Stock of the Company. b. As of February 9, 2024, the Reporting Person had sole voting power and sole dispositive power with respect to 926,376 shares of Common Stock. c. During the past sixty days, Reporting Person acquired, directly or indirectly, the following securities of the Company: Transaction Date Shares Purchased Price per Share February 7, 2024 36,374 $1.38 February 8, 2024 83,626 $1.34 February 8, 2024 73,959 $1.25 February 9, 2024 86,041 $1.32

Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer

Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer. Except with respect to the warrants held by the Reporting Person for the purchase of an aggregate of 1,359 shares of Common Stock of the Company, the Reporting Person does not have any contract, arrangement, understanding or relationship (legal or otherwise) with any person with respect to any securities of the Company, including but not limited to the transfer of voting of any of the securities, finder's fees, joint ventures, loan or option arrangements, puts or calls, guarantees of profits, division of profits or losses, or the giving or withholding of proxies.

Material to Be Filed as Exhibits

Item 7. Material to Be Filed as Exhibits. None. SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated: March 5, 2024 /s/ Dale Broadrick Dale Broadrick

View Full Filing

View this SC 13D/A filing on SEC EDGAR